Assessment of quality of life in patients with type 2 diabetes mellitus before and after starting biphasic insulin aspart 30 (BIAsp 30) therapy: IMPROVE study in Japan

By Ishii Hitoshi   Iwase Masanori   Seino Hiroaki   Shuto Yujin   Atsumi Yoshihito  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 643-650

Informa Healthcare

Access to resources Recommend Favorite

Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study

By Shestakova M.   Sharma S. K.   Almustafa M.   Min K. W.   Ayad N.   Azar S. T.   Danciulescu R.   Khutsoane D.   Guler S.  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3209-3214

Informa Healthcare

Access to resources Recommend Favorite

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT

By Strojek Krzysztof   Bebakar Wan M.W.   Khutsoane Duma T.   Pesic Milica   Šmahelová Alena   Thomsen Henrik F.   Kalra Sanjay  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2887-2894

Informa Healthcare

Access to resources Recommend Favorite

Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study

By Liebl A.   Breitscheidel L.   Nicolay C.   Happich M.  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2349-2358

Informa Healthcare

Access to resources Recommend Favorite

Biphasic insulin aspart 30 as insulin initiation or replacement therapy: the China cohort of the IMPROVE study

By Yang Wenying   Gao Yan   Liu Guoliang   Chen Lulu   Fu Zuzhi   Zou Dajin   Feng Ping   Zhao Zhigang  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 101-107

Informa Healthcare

Access to resources Recommend Favorite